Nanoengineered Red Blood Cells Loaded with TMPRSS2 and Cathepsin L Inhibitors Block SARS‐CoV‐2 Pseudovirus Entry into Lung ACE2+ Cells (Adv. Mater. 15/2024)
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Hui Yang, Jun‐Nian Zhou, Xue‐Mei Zhang, Dan‐Dan Ling, Ying‐Bao Sun, Chen‐Yan Li, Qian‐Qian Zhou, Gao‐Na Shi, Si‐Han Wang, Xiao‐Song Lin, Tao Fan, Hai‐Yang Wang, Quan Zeng, Ya‐Li Jia, Jia‐Fei Xi, Yi‐Guang Jin, Xue‐Tao Pei, Wen Yue |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Nanoengineered Red Blood Cells Loaded with TMPRSS2 and Cathepsin L Inhibitors Block SARS‐CoV‐2 Pseudovirus Entry into Lung ACE2+ Cells
by: Hui Yang, et al.
Published: (2024)
by: Hui Yang, et al.
Published: (2024)
SARS ‐ CoV ‐2 Entry Factors ACE2 , TMPRSS2 and FURIN in Salivary Glands From Primary Sjögren's Disease
by: Fernanda Aragão Felix, et al.
Published: (2025)
by: Fernanda Aragão Felix, et al.
Published: (2025)
Olive Leaf Extract Downregulates the Protein Expression of Key SARS‐CoV‐2 Entry Enzyme ACE‐2, TMPRSS2, and Furin
by: Abdurrahim Kocyigit, et al.
Published: (2024)
by: Abdurrahim Kocyigit, et al.
Published: (2024)
The flavonoid quercetin decreases ACE2 and TMPRSS2 expression but not SARS‐CoV ‐2 infection in cultured human lung cells
by: Michael James Houghton, et al.
Published: (2024)
by: Michael James Houghton, et al.
Published: (2024)
MicroRNAs modulate SARS‐CoV‐2 infection of primary human hepatocytes by regulating the entry factors ACE2 and TMPRSS2
by: Rajendra Khanal, et al.
Published: (2024)
by: Rajendra Khanal, et al.
Published: (2024)
Bridging Cancer and COVID‐19: The Complex Interplay of ACE2 and TMPRSS2
by: Xuerui Tang, et al.
Published: (2025)
by: Xuerui Tang, et al.
Published: (2025)
SARS-CoV-2 and ACE2 nexus
by: Arifuddin, Mehnaaz Sameera
Published: (2020)
by: Arifuddin, Mehnaaz Sameera
Published: (2020)
Bioassay‐guided Isolation of SARS‐CoV‐2 Viral Entry Inhibitors From the Brown Algae Lobophora variegata Identifies Fucoxanthin as a Selective ACE‐2/Spike Inhibitor
by: Victoria M. Casimir‐Montán, et al.
Published: (2025)
by: Victoria M. Casimir‐Montán, et al.
Published: (2025)
Progress of 2D Perovskite Solar Cells: Structure and Performance
by: Liyan Yang, et al.
Published: (2025)
by: Liyan Yang, et al.
Published: (2025)
Shared genetics and causal association between plasma levels of SARS‐CoV‐2 entry receptor ACE2 and Alzheimer's disease
by: Yan Zhang, et al.
Published: (2024)
by: Yan Zhang, et al.
Published: (2024)
Involvement of metformin and aging in salivary expression of ACE2 and TMPRSS2
by: Yosuke Shikama, et al.
Published: (2025)
by: Yosuke Shikama, et al.
Published: (2025)
LL‐37 Inhibits TMPRSS2 ‐Mediated S2 ' Site Cleavage and SARS‐CoV‐2 Infection but Not Omicron Variants
by: Zhenfei Bi, et al.
Published: (2025)
by: Zhenfei Bi, et al.
Published: (2025)
Low RYR2 Level Relates to Poor Prognosis of Patients With Lung Adenocarcinoma by Promoting Tumor Cell Proliferation and Inhibiting Immune Cell Infiltration
by: Tao Wang, et al.
Published: (2025)
by: Tao Wang, et al.
Published: (2025)
Proteomics and Phosphoproteomics Characteristics of the Rhesus Macaque Lung Infected With Original SARS‐CoV‐2, Delta, and Omicron Variants
by: XiaoYue Tang, et al.
Published: (2025)
by: XiaoYue Tang, et al.
Published: (2025)
The Blood‐Cerebrospinal Fluid Barrier as a Potential Entry Site for the SARS‐CoV‐2 Virus
by: Peter Solár, et al.
Published: (2025)
by: Peter Solár, et al.
Published: (2025)
Substituent‐Modulated Excited Triplet States and Activities of Ruthenium Complexes for Dual Photodynamic/Sonodynamic Therapy to Cisplatin‐Resistant Non‐Small Cell Lung Cancer
by: Dan‐Dan Xie, et al.
Published: (2024)
by: Dan‐Dan Xie, et al.
Published: (2024)
Research progress in Fc‐effector functions against SARS‐CoV‐2
by: Rongyuan Gao, et al.
Published: (2024)
by: Rongyuan Gao, et al.
Published: (2024)
In Vitro Evaluation of a Herbal Oil Combination: a Potential Phytopharmaceutical Targeting TMPRSS2, Furin, and ACE2 in SARS‐COV‐2 Infection
by: Vildan Betul Yenigun, et al.
Published: (2025)
by: Vildan Betul Yenigun, et al.
Published: (2025)
Dual MNK/VEGFR2 Inhibitor JDB153 Enhances Immunotherapeutic Efficiency and Chemosensitivity in Lung Cancer
by: Maosen Xu, et al.
Published: (2025)
by: Maosen Xu, et al.
Published: (2025)
Nanoengineered Endocytic Biomaterials for Stem Cell Therapy
by: Yingxue Wang, et al.
Published: (2024)
by: Yingxue Wang, et al.
Published: (2024)
A Human Immuno‐Lung Organoid Model to Study Macrophage‐Mediated Lung Cell Senescence Upon SARS‐CoV‐2 Infection
by: Yuling Han, et al.
Published: (2025)
by: Yuling Han, et al.
Published: (2025)
Deep Neural Network-Based Prediction of B-Cell Epitopes for SARS-CoV and SARS-CoV-2: Enhancing Vaccine Design through Machine Learning
by: Shi, Xinyu, et al.
Published: (2024)
by: Shi, Xinyu, et al.
Published: (2024)
Proteomic and Phosphoproteomic Profiling of Kidney in Rhesus Macaques With SARS‐CoV‐2 Infection
by: Yizhuo Tian, et al.
Published: (2025)
by: Yizhuo Tian, et al.
Published: (2025)
ACE2 Receptor‐Targeted Inhaled Nanoemulsions Inhibit SARS‐CoV‐2 and Attenuate Inflammatory Responses
by: Hairui Wang, et al.
Published: (2024)
by: Hairui Wang, et al.
Published: (2024)
Generation and characterization of a humanized ACE2 mouse model to study long‐term impacts of SARS‐CoV‐2 infection
by: Chang‐Yong Choi, et al.
Published: (2024)
by: Chang‐Yong Choi, et al.
Published: (2024)
Cs 2 CO 3 ‐Promoted Synthesis of Guanidinobispyrimidine Derivatives as Potential Breast Cancer Cell Inhibitors
by: Yu Xu, et al.
Published: (2025)
by: Yu Xu, et al.
Published: (2025)
Engineering Red Blood Cells for Amplified Tumor Dual‐Gas Transfusion Therapy (Adv. Mater. 38/2025)
by: Tao Li, et al.
Published: (2025)
by: Tao Li, et al.
Published: (2025)
A Chip‐Based Surveillance Platform for Detecting Antibody‐Based Immunity and Immune Escape Using SARS‐CoV‐2 Pseudovirus Surrogates
by: Maisha M. Feroz, et al.
Published: (2025)
by: Maisha M. Feroz, et al.
Published: (2025)
Chronological Effects of Immune Checkpoint Inhibitors in Non‐Small Cell Lung Cancer
by: Xinyue Guo, et al.
Published: (2025)
by: Xinyue Guo, et al.
Published: (2025)
In Silico and In Vitro Identification of New Eugenol Derivatives as Inhibitors of the Spike SARS ‐ CoV ‐2 Protein Interaction With the ACE2 Host Receptor
by: Timoteo Delgado‐Maldonado, et al.
Published: (2025)
by: Timoteo Delgado‐Maldonado, et al.
Published: (2025)
Biomimetic Copper Nanoparticles Coated with ACE2‐Overexpressing Membranes for Selective SARS‐CoV‐2 Neutralization and Disinfection
by: Pooja Aich, et al.
Published: (2026)
by: Pooja Aich, et al.
Published: (2026)
ACE2 diversity in placental mammals reveals the evolutionary strategy of SARS-CoV-2
by: Sampaio de Oliveira Fam, Bibiana, et al.
Published: (2020)
by: Sampaio de Oliveira Fam, Bibiana, et al.
Published: (2020)
An RBC-MsUQ Framework for Red Blood Cell Morpho-Mechanics
by: Wang, Shuo, et al.
Published: (2025)
by: Wang, Shuo, et al.
Published: (2025)
Synaptic Potentiation in Hippocampus by eEF2K Inhibitor A484954
by: Qian Yang, et al.
Published: (2026)
by: Qian Yang, et al.
Published: (2026)
Molecular and Functional Characterization of Sika Deer ACE2 as a Receptor for SARS‐CoV‐2
by: Anastasiia Kovba, et al.
Published: (2025)
by: Anastasiia Kovba, et al.
Published: (2025)
A Novel Prophylaxis Strategy Using Ecotin as A Promising Adjuvant for Fc‐RBD Fusion Protein Vaccine of SARS ‐ CoV ‐2
by: Yakun Sun, et al.
Published: (2025)
by: Yakun Sun, et al.
Published: (2025)
Folic Acid Protects Against Radiation‐Induced Lung Injury by Suppressing Senescence of Lung Epithelial Cells
by: Li Zhong, et al.
Published: (2025)
by: Li Zhong, et al.
Published: (2025)
Ozanimod and Prazosin as Inhibitor of bonding SARS‐CoV‐2 spike protein and the ACE2 enzyme: Molecular Dynamics and Molecular Docking Study of Potential Drugs
by: Maryam Hosseinzadeh, et al.
Published: (2024)
by: Maryam Hosseinzadeh, et al.
Published: (2024)
SARS‐CoV‐2 Membrane Protein Induces MARCHF1/GPX4‐Mediated Ferroptosis by Promoting Lipid Accumulation
by: Pei Sun, et al.
Published: (2025)
by: Pei Sun, et al.
Published: (2025)
Large‐Scale Screening of CD4+ T‐Cell Epitopes From SARS‐CoV‐2 Proteins and the Universal Detection of SARS‐CoV‐2 Specific T Cells for Northeast Asian Population
by: Yu Zhao, et al.
Published: (2025)
by: Yu Zhao, et al.
Published: (2025)
Similar Items
-
Nanoengineered Red Blood Cells Loaded with TMPRSS2 and Cathepsin L Inhibitors Block SARS‐CoV‐2 Pseudovirus Entry into Lung ACE2+ Cells
by: Hui Yang, et al.
Published: (2024) -
SARS ‐ CoV ‐2 Entry Factors ACE2 , TMPRSS2 and FURIN in Salivary Glands From Primary Sjögren's Disease
by: Fernanda Aragão Felix, et al.
Published: (2025) -
Olive Leaf Extract Downregulates the Protein Expression of Key SARS‐CoV‐2 Entry Enzyme ACE‐2, TMPRSS2, and Furin
by: Abdurrahim Kocyigit, et al.
Published: (2024) -
The flavonoid quercetin decreases ACE2 and TMPRSS2 expression but not SARS‐CoV ‐2 infection in cultured human lung cells
by: Michael James Houghton, et al.
Published: (2024) -
MicroRNAs modulate SARS‐CoV‐2 infection of primary human hepatocytes by regulating the entry factors ACE2 and TMPRSS2
by: Rajendra Khanal, et al.
Published: (2024)